Filing Details
- Accession Number:
- 0000950170-24-041790
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-04-04 16:00:48
- Reporting Period:
- 2024-04-02
- Accepted Time:
- 2024-04-04 16:00:48
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1527599 | Synlogic Inc. | SYBX | Pharmaceutical Preparations (2834) | 261824804 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
2015112 | Beth Mary Dooley | C/O Synlogic, Inc. 301 Binney Street, Suite 402 Cambridge MA 02142 | Head Of Finance | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2024-04-02 | 188 | $1.73 | 15,231 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- Represents the number of shares sold by the reporting person on April 2, 2024 to cover the tax liability in connection with the vesting of four restricted stock awards, vesting on April 1, 2024, that were granted in 2020, 2021, 2022 and 2023.